Clinical Trial Update: Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer [Phase 1]

View source ↗

Summary

Phase 1 trial comparing autologous mesenchymal stem cells with autologous mononuclear cells for diabetic critical limb ischemia and foot ulcers; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)
• Autologous mononuclear cells (mononuclear cells)

Snippet

Sponsor: Third Military Medical University | Conditions: Autologous Transplantation, Diabetic Foot | Phase 1 | Status: COMPLETED